218 related articles for article (PubMed ID: 33253517)
21. An eight-miRNA signature expression-based risk scoring system for prediction of survival in pancreatic adenocarcinoma.
Dou D; Yang S; Lin Y; Zhang J
Cancer Biomark; 2018; 23(1):79-93. PubMed ID: 29991127
[TBL] [Abstract][Full Text] [Related]
22. Bioinformatic mining and validation of the effects of ferroptosis regulators on the prognosis and progression of pancreatic adenocarcinoma.
Xu F; Zhang Z; Zhao Y; Zhou Y; Pei H; Bai L
Gene; 2021 Aug; 795():145804. PubMed ID: 34175402
[TBL] [Abstract][Full Text] [Related]
23. Postoperative prognosis prediction of pancreatic cancer with seven microRNAs.
Lee KH; Lee JK; Choi DW; Do IG; Sohn I; Jang KT; Jung SH; Heo JS; Choi SH; Lee KT
Pancreas; 2015 Jul; 44(5):764-8. PubMed ID: 25906450
[TBL] [Abstract][Full Text] [Related]
24. Integrated microRNA-mRNA analysis of pancreatic ductal adenocarcinoma.
Liu PF; Jiang WH; Han YT; He LF; Zhang HL; Ren H
Genet Mol Res; 2015 Aug; 14(3):10288-97. PubMed ID: 26345967
[TBL] [Abstract][Full Text] [Related]
25. miRNA and Gene Expression in Pancreatic Ductal Adenocarcinoma.
Tesfaye AA; Azmi AS; Philip PA
Am J Pathol; 2019 Jan; 189(1):58-70. PubMed ID: 30558723
[TBL] [Abstract][Full Text] [Related]
26. Molecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic value.
Namkung J; Kwon W; Choi Y; Yi SG; Han S; Kang MJ; Kim SW; Park T; Jang JY
J Gastroenterol Hepatol; 2016 Jun; 31(6):1160-7. PubMed ID: 26644397
[TBL] [Abstract][Full Text] [Related]
27. A comprehensive study of construction and analysis of competitive endogenous RNA networks in lung adenocarcinoma.
Gu C; Shi X; Huang Z; Chen J; Yang J; Shi J; Pan X
Biochim Biophys Acta Proteins Proteom; 2020 Aug; 1868(8):140444. PubMed ID: 32423886
[TBL] [Abstract][Full Text] [Related]
28. Identification of a 4-miRNA signature as a potential prognostic biomarker for pancreatic adenocarcinoma.
Wang ZX; Deng TX; Ma Z
J Cell Biochem; 2019 Oct; 120(10):16416-16426. PubMed ID: 31297864
[TBL] [Abstract][Full Text] [Related]
29. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
Lu M; Kong X; Wang H; Huang G; Ye C; He Z
Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
[TBL] [Abstract][Full Text] [Related]
31. Identification of a Multi-RNA-Type-Based Signature for Recurrence-Free Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma.
Wang P; Zeng Z; Shen X; Tian X; Ye Q
DNA Cell Biol; 2020 Apr; 39(4):615-630. PubMed ID: 32105510
[TBL] [Abstract][Full Text] [Related]
32. Identification of prognostic lipid droplet-associated genes in pancreatic cancer patients via bioinformatics analysis.
Bai R; Rebelo A; Kleeff J; Sunami Y
Lipids Health Dis; 2021 Jun; 20(1):58. PubMed ID: 34078402
[TBL] [Abstract][Full Text] [Related]
33. Molecular Analysis of Vascular Endothelial Growth Factor (VEGF) Receptors in EUS-guided Samples Obtained from Patients with Pancreatic Adenocarcinoma.
Costache MI; Iordache S; Costache CA; Dragos E; Dragos A; Saftoiu A
J Gastrointestin Liver Dis; 2017 Mar; 26(1):51-57. PubMed ID: 28338114
[TBL] [Abstract][Full Text] [Related]
34. Microarray data analysis on gene and miRNA expression to identify biomarkers in non-small cell lung cancer.
Jin X; Guan Y; Zhang Z; Wang H
BMC Cancer; 2020 Apr; 20(1):329. PubMed ID: 32299382
[TBL] [Abstract][Full Text] [Related]
35. Integrated Analysis of Multi-Omics Data to Identify Prognostic Genes for Pancreatic Cancer.
Jiang F; Huang X; Zhang F; Pan J; Wang J; Hu L; Chen J; Wang Y
DNA Cell Biol; 2022 Mar; 41(3):305-318. PubMed ID: 35104421
[TBL] [Abstract][Full Text] [Related]
36. Five miRNAs considered as molecular targets for predicting neuroglioma.
Yang H; Wang Y
Tumour Biol; 2016 Jan; 37(1):1051-9. PubMed ID: 26269115
[TBL] [Abstract][Full Text] [Related]
37. A panel of 8 miRNAs as a novel diagnostic biomarker in pancreatic cancer.
Deng B; Wang M; Liu Z
Medicine (Baltimore); 2020 Sep; 99(38):e22261. PubMed ID: 32957376
[TBL] [Abstract][Full Text] [Related]
38. Identification of miRNA biomarkers for stomach adenocarcinoma.
Qian H; Cui N; Zhou Q; Zhang S
BMC Bioinformatics; 2022 May; 23(1):181. PubMed ID: 35578189
[TBL] [Abstract][Full Text] [Related]
39. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
[TBL] [Abstract][Full Text] [Related]
40. miRFA: an automated pipeline for microRNA functional analysis with correlation support from TCGA and TCPA expression data in pancreatic cancer.
Borgmästars E; de Weerd HA; Lubovac-Pilav Z; Sund M
BMC Bioinformatics; 2019 Jul; 20(1):393. PubMed ID: 31311505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]